Prot# CT-BI Vacc-4x 2007/1: A Phase II, Randomized, Double-Blind, Multicenter, Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected with HIV-1 Who Have Maintained an Adequate Response to ART

Project: Research project

Project Details

StatusFinished
Effective start/end date11/14/08 → 11/13/11

Funding

  • Constella Group, Ltd. (CT-BI Vacc-4x 2007/1)
  • Bionor Immuno AS (CT-BI Vacc-4x 2007/1)